Susceptibility of Nocardia asteroides to new quinolones and beta-lactams.
AUTOR(ES)
Gombert, M E
RESUMO
The susceptibility of 31 strains of Nocardia asteroides to various quinolones and beta-lactams, as well as coumermycin, amikacin, and minocycline, was determined by the agar dilution technique. Ciprofloxacin was the most active fluoroquinolone tested on a weight basis, as it inhibited approximately 50% of the isolates at achievable drug levels in serum. Ceftriaxone and cefpirome were the most active cephalosporins in this system with MICs of 8 micrograms/ml for 80% of strains tested. Imipenem, amikacin, and minocycline were the most effective agents tested.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=175847Documentos Relacionados
- Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 beta-lactams.
- Resistance of Pseudomonas aeruginosa to new beta-lactamase-resistant beta-lactams.
- Susceptibility of Nocardia asteroides to various antibiotics, including newer beta-lactams, trimethoprim-sulfamethoxazole, amikacin, and N-formimidoyl thienamycin.
- Penicillin-binding proteins and bacterial resistance to beta-lactams.
- Effects of Asp-179 mutations in TEMpUC19 beta-lactamase on susceptibility to beta-lactams.